Bentley Pharmaceuticals to Present at the UBS Global Specialty Pharmaceuticals Conference EXETER, N.H., May 24 /PRNewswire-FirstCall/ -- Bentley Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on advanced drug-delivery technologies, which also manufactures and markets generic and branded products in Europe, announced today that Michael D. Price, Vice President and Chief Financial Officer of the Company, will be presenting at the UBS Global Specialty Pharmaceuticals Conference at the Grand Hyatt in New York, NY. The presentation is scheduled for Tuesday, May 25, 2004 at 3:00 p.m. (EDT). The presentation will be broadcast live over the Internet and may be accessed via the Company's website, http://www.bentleypharm.com/. In addition, a replay of the presentation will be available beginning three hours after the presentation time and will remain available through June 27, 2004. Follow the above instructions to access the replay. Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and pharmaceutical products. Bentley's proprietary drug technologies enhance or facilitate the absorption of pharmaceutical compounds across various membranes. Bentley also manufactures and markets a growing portfolio of generic and branded pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal, infectious and neurological diseases through its subsidiaries, Laboratorios Belmac, Laboratorios Davur and Laboratorios Rimafar; and manufactures and sells active pharmaceutical ingredients through its subsidiary, Bentley API. Copies of Bentley Pharmaceuticals' press releases and other information may be obtained through Bentley's web site at http://www.bentleypharm.com/. DATASOURCE: Bentley Pharmaceuticals, Inc. CONTACT: Michael D. Price, Vice President, Chief Financial Officer of Bentley Pharmaceuticals, Inc., +1-603-658-6100; Investors - Jonathan Birt, Lanie Marcus or Media - Sean Leous, all of Financial Dynamics, +1-212-850-5600, for Bentley Pharmaceuticals, Inc. Web site: http://www.bentleypharm.com/

Copyright